Aegis Medicines Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 6.24 Cr
- Company Age 31 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 55.24 Cr
- Revenue Growth 12.50%
- Profit Growth -786459.51%
- Ebitda -4201.54%
- Net Worth -810.24%
- Total Assets -1.66%
About Aegis Medicines
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U99999PN1993PTC073083
-
Company No.
073083
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Jul 1993
-
Date of AGM
16 Aug 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Aegis Medicines?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ayub Syed
|
Director | 23-Jul-1993 | Current |
|
Ayesha Syed
|
Director | 23-Jul-1993 | Current |
Financial Performance of Aegis Medicines.
Aegis Medicines Pvt Ltd, for the financial year ended 2021, experienced significant growth in revenue, with a 12.5% increase. The company also saw a substantial fall in profitability, with a 786459.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 810.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aegis Medicines?
In 2021, Aegis Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aegis Ampoules And Vials LimitedAyub Syed and Ayesha Syed are mutual person
-
Aegis Forging LimitedAyub Syed is a mutual person
-
Aegis Glass Containers Private Limited
Ayub Syed and Ayesha Syed are mutual person
Charges (Loans)
₹55.24 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 55.24 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jan 2013 | State Bank Of India | ₹32.02 Cr | Open |
| 31 Dec 2009 | State Bank Of India | ₹23.22 Cr | Open |
How Many Employees Work at Aegis Medicines?
Unlock and access historical data on people associated with Aegis Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aegis Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aegis Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
